Anne Vergison

Summary

Country: Belgium

Publications

  1. ncbi Microbiology of otitis media: a moving target
    Anne Vergison
    Department of Paediatric Infectious Diseases, Universite Libre de Bruxelles, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium
    Vaccine 26:G5-10. 2008
  2. ncbi Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough
    Anne Vergison
    Department of Pediatric Infectious Diseases, Infection Control and Hospital Epidemiology Unit, Universite Libre de Bruxelles, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium
    Pediatrics 118:e801-9. 2006
  3. ncbi National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients
    A Vergison
    Department of Pediatric Infectious Diseases, Hospital Epidemiology and Infection Control Unit, Universite Libre de Bruxelles, Hôpital des Enfants Reine Fabiola, Brussels, Belgium
    J Antimicrob Chemother 59:893-9. 2007
  4. ncbi Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape
    Pierre Robert Smeesters
    Infectious Diseases Department, Hopital Universitaire des Enfants Reine Fabiola, Universite Libre de Bruxelles, Brussels, Belgium Laboratoire de Génétique des Procaryotes, Institut de Biologie et de Médecine Moléculaires, Universite Libre de Bruxelles, Brussels, Belgium Pediatric Department, Hospital Universitario de Brasilia, Universidade de Brasilia, Brasilia, Brazil
    PLoS ONE 1:e10. 2006
  5. ncbi Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 29:2856-64. 2011
  6. ncbi Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development
    Pierre R Smeesters
    Laboratoire de Génétique et Physiologie Bactérienne, Institut de Biologie et de Médecine Moléculaires, Faculte des Sciences, Universite Libre de Bruxelles, 12 rue des Professeurs Jeener et Brachet, 6041 Gosselies, Belgium
    Vaccine 26:5835-42. 2008
  7. ncbi Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations
    Hoang Anh Nguyen
    Unité de Pharmacologie Cellulaire et Moléculaire, Universite Catholique de Louvain, Brussels, Belgium
    Antimicrob Agents Chemother 53:1443-9. 2009
  8. ncbi Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
    Hoang Anh Nguyen
    Louvain Drug Research Institute, Unité de Pharmacologie Cellulaire et Moléculaire, Universite Catholique de Louvain, Brussels, Belgium
    Antimicrob Agents Chemother 53:1434-42. 2009
  9. ncbi Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 28:3920-8. 2010
  10. ncbi Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations
    Pierre Robert Smeesters
    Laboratoire de Génétique et Physiologie Bactérienne, Institut de Biologie et de Médecine Moléculaires IBMM, Faculte des Sciences, Universite Libre de Bruxelles, 12 rue des Professeurs Jeener et Brachet, 6041 Gosselies, Belgium
    Int J Antimicrob Agents 34:44-9. 2009

Detail Information

Publications18

  1. ncbi Microbiology of otitis media: a moving target
    Anne Vergison
    Department of Paediatric Infectious Diseases, Universite Libre de Bruxelles, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium
    Vaccine 26:G5-10. 2008
    ..This paper will discuss the causes and consequences of recent shifts in the underlying microbiology of AOM...
  2. ncbi Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough
    Anne Vergison
    Department of Pediatric Infectious Diseases, Infection Control and Hospital Epidemiology Unit, Universite Libre de Bruxelles, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium
    Pediatrics 118:e801-9. 2006
    ..In Belgium, as in most European countries, surveillance relies on voluntary passive reporting from microbiology laboratories; therefore, reported incidence rates are probably inaccurate...
  3. ncbi National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients
    A Vergison
    Department of Pediatric Infectious Diseases, Hospital Epidemiology and Infection Control Unit, Universite Libre de Bruxelles, Hôpital des Enfants Reine Fabiola, Brussels, Belgium
    J Antimicrob Chemother 59:893-9. 2007
    ..We conducted a multicentre survey to determine the prevalence of S. aureus and MRSA colonization in Belgian CF patients and characterize the phenotype and clonal distribution of their staphylococcal strains...
  4. ncbi Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape
    Pierre Robert Smeesters
    Infectious Diseases Department, Hopital Universitaire des Enfants Reine Fabiola, Universite Libre de Bruxelles, Brussels, Belgium Laboratoire de Génétique des Procaryotes, Institut de Biologie et de Médecine Moléculaires, Universite Libre de Bruxelles, Brussels, Belgium Pediatric Department, Hospital Universitario de Brasilia, Universidade de Brasilia, Brasilia, Brazil
    PLoS ONE 1:e10. 2006
    ..Group A Streptococcus (GAS) clinical and molecular epidemiology varies with location and time. These differences are not or are poorly understood...
  5. ncbi Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 29:2856-64. 2011
    ..Estimation of PCV7 impact comparing pre- and post-vaccination data should adjust for pre-vaccine trends, and serotype dynamics need further exploration...
  6. ncbi Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development
    Pierre R Smeesters
    Laboratoire de Génétique et Physiologie Bactérienne, Institut de Biologie et de Médecine Moléculaires, Faculte des Sciences, Universite Libre de Bruxelles, 12 rue des Professeurs Jeener et Brachet, 6041 Gosselies, Belgium
    Vaccine 26:5835-42. 2008
    ....
  7. ncbi Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations
    Hoang Anh Nguyen
    Unité de Pharmacologie Cellulaire et Moléculaire, Universite Catholique de Louvain, Brussels, Belgium
    Antimicrob Agents Chemother 53:1443-9. 2009
    ..Rifampin and moxifloxacin were additive. This approach may help in better assessing and improving the activity of antibiotics against intracellular SCV strains...
  8. ncbi Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
    Hoang Anh Nguyen
    Louvain Drug Research Institute, Unité de Pharmacologie Cellulaire et Moléculaire, Universite Catholique de Louvain, Brussels, Belgium
    Antimicrob Agents Chemother 53:1434-42. 2009
    ..The data may help rationalizing the design of further studies with intracellular SCV strains...
  9. ncbi Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 28:3920-8. 2010
    ..PCV impact was monitored in 11/15 countries using it. We propose steps for the monitoring of incidence rates and serotype distribution at EU level, to assess the need to introduce PCV and monitor its impact once introduced...
  10. ncbi Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations
    Pierre Robert Smeesters
    Laboratoire de Génétique et Physiologie Bactérienne, Institut de Biologie et de Médecine Moléculaires IBMM, Faculte des Sciences, Universite Libre de Bruxelles, 12 rue des Professeurs Jeener et Brachet, 6041 Gosselies, Belgium
    Int J Antimicrob Agents 34:44-9. 2009
    ..All the Brazilian and Belgian emm type 6 strains displayed a S79A/F mutation in parC that convincingly explains the non-susceptible phenotype...
  11. ncbi Group A Streptococcus virulence and host factors in two toddlers with rheumatic fever following toxic shock syndrome
    Pierre Robert Smeesters
    Laboratoire de Génétique et Physiologie Bactérienne, Institut de Biologie et de Médecine Moléculaires, Faculte des Sciences, Universite Libre de Bruxelles, 12 rue des Professeurs Jeener et Brachet, B6041 Gosselies, Belgium
    Int J Infect Dis 14:e403-9. 2010
    ..The present report describes the bacterial and host determinants in non-related toddlers who developed RF diagnostic criteria after toxic shock syndrome (TSS)...
  12. ncbi Otitis media and its consequences: beyond the earache
    Anne Vergison
    Universite Libre de Bruxelles, Brussels, Belgium
    Lancet Infect Dis 10:195-203. 2010
    ..Prevention of acute otitis media with existing and future viral and bacterial vaccines seems the most promising approach to affect disease burden and consequences, both in developed and developing countries...
  13. ncbi Pharyngitis in low-resources settings: a pragmatic clinical approach to reduce unnecessary antibiotic use
    Pierre Robert Smeesters
    Servico de Pediatria, Hospital Universitario de Brasilia, Universidade de Brasilia, Brasilia, Brazil
    Pediatrics 118:e1607-11. 2006
    ....
  14. ncbi Impact of rotavirus vaccination on laboratory confirmed cases in Belgium
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 29:4698-703. 2011
    ..7-81.4%). The rotavirus season was delayed compared to pre-vaccination seasons. Laboratory data provide a crude estimation of vaccination impact, but analysis of in-patient data will be needed to assess the impact on severe disease...
  15. ncbi Enteroviral infection of a cardiac prosthetic device
    Sophie Blumental
    Pediatric Infectious Disease Unit, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium
    Clin Infect Dis 52:710-6. 2011
    ..Identification of the causative pathogen may be challenging in culture negative infective endocarditis (IE)...
  16. ncbi Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey
    Sophie Blumental
    Pediatric Infectious Diseases Unit, Hopital Universitaire des Enfants Reine Fabiola HUDERF, Brussels, Belgium
    BMC Infect Dis 11:313. 2011
    ..During the 2009 influenza A/H1N1v pandemic, children were identified as a specific "at risk" group. We conducted a multicentric study to describe pattern of influenza A/H1N1v infection among hospitalized children in Brussels, Belgium...
  17. ncbi Kytococcus schroeteri infection of a ventriculoperitoneal shunt in a child
    Sarah Jourdain
    Infectious Diseases and Infection Control Unit, Universite Libre de Bruxelles, Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium
    Int J Infect Dis 13:e153-5. 2009
    ..Initially identified as a Micrococcus spp. by both automated identification and conventional biochemical testing, sequencing of the 16S ribosomal RNA gene enabled accurate identification of the organism...
  18. ncbi Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium
    O Denis
    Laboratoire de Référence MRSA Staphylocoques, Department of Microbiology, Hopital Erasme, Universite Libre de Bruxelles, Brussels, Belgium
    J Antimicrob Chemother 56:1103-6. 2005
    ..The objective of this study was to describe the molecular characteristics of the first PVL-positive MRSA strains isolated in Belgium...